<unk> , commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P is a second COVID-19 vaccine developed by the Kazakh Biosafety Research Institute and in clinical trials.
QazCovid-in
Cephem
Azficel-T
Prosultiamine
Chloroquine
K-Quarantine
MedMagLabs
Crisaborole